Retatrutide is an investigational once-weekly peptide being evaluated in authorised clinical trials for obesity and related metabolic conditions. It acts as a triple agonist at the GIP, GLP-1 and glucagon receptors and has not been approved for commercial or personal use.
NAD+ 1000mg is a high-dose formulation of nicotinamide adenine dinucleotide, an essential coenzyme naturally present in living cells. It is not a peptide, but a dinucleotide coenzyme involved in cellular energy production, redox reactions and DNA-repair pathways.
MOTS-c is a naturally occurring mitochondrial-derived peptide involved in cellular energy regulation and metabolic signalling. Originally identified in 2015, it remains an active area of scientific research for its role in metabolic adaptation and exercise-related pathways.
Svelta Labs Tirzepatide Pen is a once-weekly, pre-filled prescription treatment intended to support weight management alongside a reduced-calorie diet and increased physical activity. Treatment must be prescribed following an appropriate clinical assessment and used exactly as directed by a qualified healthcare professional.
Svelta Labs Glow Pen is a pre-filled, multi-dose research device containing a precisely formulated blend of GHK-Cu, BPC-157 and TB-500. Designed for convenient handling and accurate administration in controlled research settings.
CJC-1295 no DAC and Ipamorelin research blend for GH-axis and recovery-signalling study models.
At Svelta Labs, we do not leave progress to chance—we make it happen through science-led products designed to support weight management, everyday wellbeing and healthier-looking skin.
Enter your email and we will attach the launch reward code to your enquiry so it can be used against checkout.
